Koronis Pharmaceuticals
From Wikipedia, the free encyclopedia
For other uses, see Coronis (mythology) and Koronis family.
 |
This article relies too much on references to primary sources. (April 2009) |
Koronis Pharmaceuticals is a Seattle area biotechnology company founded in 1998. Koronis is dedicated to the development of antiviral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA). The Company’s lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV) infection. The company also has products in development for the treatment of hepatitis C and RSV infection.
External links[edit]
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
